Financials data is unavailable for this security.
Cash flow in CADView more
In 2024, cash reserves at Medicenna Therapeutics Corp fell by 16.61m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 16.26m for operations while cash used for investing totalled .
Cash flow per share | -0.3681 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2603 |
---|---|
Tangible book value per share | 0.2596 |
More ▼
Balance sheet in CADView more
Current ratio | 11.40 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0088 |
---|---|
Total debt/total capital | 0.0087 |
More ▼